The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
Open accessAbstract
Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database [1]. Different bone tumour subtypes have distinct patterns of incidence, and each has no more than 0.3 incident cases per 100 000 per year. Osteosarcoma (OS) and Ewing sarcoma (ES) have a relatively high incidence in the second decade of life, whereas chondrosarcoma (CS) is more common in older age [2–4].
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These strata were based on studies showing that a shorter relapse-free interval and older age are prognostic for shorter OS in patients with osteosarcoma.”
From Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma (2024) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Self-citationGrier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Self-citationGrünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854
Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., Marcus, K., Sailer, S., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 757
The Clinical Approach Towards Chondrosarcoma
Gelderblom, H., Hogendoorn, P. C. W., Dijkstra, S. D., van Rijswijk, C. S., Krol, A. D., Taminiau, A. H. M., & Bovée, J. V. M. G. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0237 · Cited by 756
Self-citation
Cited by
Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy096 · Cited by 1,614
Self-citationBeird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Self-citationSurgery in reference centers improves survival of sarcoma patients: a nationwide study
Blay, J.-Y., Honoré, C., Stoeckle, E., Meeus, P., Jafari, M., Gouin, F., Anract, P., Ferron, G., Rochwerger, A., Ropars, M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz124 · Cited by 338
Self-citationMolecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Self-citationLilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 283
Metadata
- Authors
- Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Morland, B., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Strauss, S. J., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W. T. A., Whelan, J., Wardelmann, E., Zaikova, O., & Blay, J. Y.
- Affiliations
- University of Milan (IT)
- Olgahospital (DE)
- Instituto Português de Oncologia Francisco Gentil (PT)
- Turku University Hospital (FI)
- Essen University Hospital (DE)
- Istituti Fisioterapici Ospitalieri (IT)
- Institut Curie (FR)
- Royal Manchester Children's Hospital (GB)
- Vienna General Hospital (AT)
- Hospital Universitario Virgen del Rocío (ES)
- Institut Gustave Roussy (FR)
- Centro di Riferimento Oncologico (IT)
- University College London Hospitals NHS Foundation Trust (GB)
- Ghent University Hospital (BE)
- Skåne University Hospital (SE)
- Ospedale Regina Margherita (IT)
- Russian Cancer Research Center NN Blokhin (RU)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Istituto Ortopedico Rizzoli (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Leiden University Medical Center (NL)
- Institut Jules Bordet (BE)
- Candiolo Cancer Institute (IT)
- University of Mannheim (DE)
- Ludwig-Maximilians-Universität München (DE)
- Helsinki University Hospital (FI)
- Royal Marsden Hospital (GB)
- Institute of Cancer Research (GB)
- University Medical Center Groningen (NL)
- Radboud University Medical Center (NL)
- St Anna Children's Hospital (AT)
- Masaryk Memorial Cancer Institute (CZ)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Tel Aviv Sourasky Medical Center (IL)
- Centre Hospitalier Universitaire Vaudois (CH)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Hospital de Sant Pau (ES)
- Helios Hospital Berlin-Buch (DE)
- Weston Park Cancer Centre (GB)
- Aarhus University Hospital (DK)
- Universitair Ziekenhuis Leuven (BE)
- Erasmus MC Cancer Institute (NL)
- Institute of Oncology Ljubljana (SI)
- University Hospital Münster (DE)
- Oslo University Hospital (NO)
- Lyon 1 Université (FR)
- ORCID
- Casali, P.G.
- Bielack, S.
- Aro, H.T.
- Bauer, S.
- Biagini, R.
- Bonvalot, S.
- Brennan, B.
- Brugières, L.
- Buonadonna, A.
- Dileo, P.
- Dhooge, C.
- Fagioli, F.
- Ferraresi, V.
- Ferrari, A.
- Ferrari, S.
- Frezza, A.M.
- Gaspar, N.
- Gelderblom, H.
- Gil, T.
- Grignani, G.
- Gronchi, A.
- Haas, R.L.
- Hohenberger, P.
- Issels, R.
- Joensuu, H.
- Jones, R.L.
- Judson, I.
- Jutte, P.
- Kaal, S.
- Kager, L.
- Kasper, B.
- Krákorová, D.A.
- Ladenstein, R.
- Lugowska, I.
- Montemurro, M.
- Morland, B.
- Pantaleo, M.A.
- Piana, R.
- Picci, P.
- Piperno-Neumann, S.
- Reichardt, P.
- Rutkowski, P.
- Safwat, A.A.
- Schöffski, P.
- Sleijfer, S.
- Stacchiotti, S.
- Strauss, S.J.
- Unk, M.
- Whelan, J.
- Wardelmann, E.
- Zaikova, O.
- Blay, J.Y.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv79-iv95
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2894974756
- Cited by
- 617
- References
- 125
- Citations by year
- 2026: 46 · 2025: 48 · 2024: 84 · 2023: 82 · 2022: 107 · 2021: 133 · 2020: 80 · 2019: 32 · 2018: 3
- FWCI
- 46.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IRIS (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Ariad Pharmaceuticals
- Medpace
- Stryker
- Exelixis
- Eisai
- Astellas Pharma
- Swedish Orphan Biovitrum
- PharmaMar
- Ipsen
- Plexxikon
- Loxo Oncology
- Daiichi Sankyo Europe
- EIT Health
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Keywords
- bone sarcoma, osteosarcoma, Ewing sarcoma, chondrosarcoma, pediatric bone tumors, diagnosis, treatment, follow-up, incidence
- MeSH terms
- Positron Emission Tomography Computed Tomography, Survivorship, Adult, Aftercare, Age Factors, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone and Bones, Bone Neoplasms, Child, Europe, Humans, Long-Term Care, Magnetic Resonance Imaging, Medical Oncology, Neoplasm Staging, Patient Participation, Radionuclide Imaging, Osteosarcoma, Self-Help Groups, Societies, Medical, Incidence, Treatment Outcome, Radiotherapy, Adjuvant, Orthopedic Procedures, Neoadjuvant Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. https://app.cochat.ai/papers/10.1093/annonc/mdy310
- The paper
- Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., . . . Blay, J. Y. (2018). Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. https://doi.org/10.1093/annonc/mdy310
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.